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Edited by Noboru MizushimaAbstract Nuclear factor of activated T cells (NFATc4) has
been implicated as a critical regulator of the cardiac development
and hypertrophy. However, the mechanisms for regulating
NFATc4 stability and transactivation remain unclear. We
showed that NFATc4 protein was predominantly ubiquitinated
through the formation of Lysine 48-linked polyubiquitin chains,
and this modiﬁcation decreased NFATc4 protein levels and its
transcriptional activity. Furthermore, activation of GSK3b
markedly enhanced NFATc4 ubiquitination and decreased its
transactivation, whereas inhibition of GSK3b had opposite ef-
fects. Importantly, ubiquitination and phosphorylation induced
by GSK3b repressed NFATc4-dependent cardiac-speciﬁc gene
expression. These results demonstrate that the ubiquitin–protea-
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Cardiac gene expression1. Introduction
Nuclear factors of activated T cells (NFATs) are members
of REL-homology domain (RHD)-containing transcription
factors [1,2]. Today, ﬁve members of the NFAT family of
transcription factors have been identiﬁed. Four of them are*Corresponding author. Fax: +86 10 6529 6494.
E-mail address: hhli1995@yahoo.com (H. Li).
0014-5793/$34.00  2008 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2008.11.009regulated by the calcium/calmodulin-dependent phosphatase
calcineurin, including NFAT1 (NFAT c2/p), NFAT2
(NFATc1/c), NFAT3 (NFATc4), and NFAT4 (NFATc3/x).
In resting cells, NFAT proteins exist in the cytoplasm as
phosphoproteins and their activation requires dephosphoryl-
ation. Upon stimulation, elevation of cytoplasmic free Ca2+
concentration enhances calcineurin activity, which dephos-
phorylates NFATs and leads to their activation [1,2]. Con-
versely, NFATs are phosphorylated by several protein
kinases, including glycogen synthase kinase-3b (GSK3b)
[3,4] and deactivated in the cytoplasm in resting cells. Thus,
nuclear translocation of NFATs is essential for their tran-
scriptional activity.
Earlier studies have reported the presence of NFATc1,
NFATc2, and NFATc3 mainly in T cells regulating the
expression of cytokine genes such as interleukin-2 (IL-2)
[1,2]. However, recent studies demonstrate that all ﬁve
NFAT isoforms are expressed in the ventricular cardiomyo-
cytes [1,5–7]. The cardiovascular system is dependent on
NFAT activity for embryonic development and for adult
adaptation to cardiac stress [8]. Mice with disruption of
NFATc3/c4 genes die around E11 with defects in vessel wall
assembly [9]. Recent studies demonstrate that NFATc4 is an
important regulator for cardiac hypertrophy [10–12]. How-
ever, the mechanisms for regulating NFATc4 protein stabil-
ity and transactivation are still poorly understood. In the
present study, we showed that NFATc4 protein is predomi-
nantly ubiquitinated through the formation of K48-linked
polyubiquitin chain. The modiﬁcations of ubiquitination
and phosphorylation induced by GSK3b play an important
role in regulating NFATc4 stability and transactivation.2. Materials and methods
2.1. Plasmids and reagents
The Luciferase reporter plasmids NFAT/AP-1-Luc and PPAR-Luc
were provided by Dr. Chiwing Chow. His- or HA-ubiquitin (wild-
type, K48R) and antisense HA-Ub were from Dr. Kuan-Teh Jeang.
Active form and dominant-negative form of GSK3b (Ac GSK3b and
Dn-GSK3b) were obtained from Dr. Renliang Wu. The IL-2-Luc re-
porter and Flag-NFATc4 plasmids have been described previously
[13]. The RNA Oligo GSK3ß siRNA (sc-35525) and control siRNA
(sc-37007) were obtained from Santa Cruz Biotechnology. The anti-
bodies used: anti-Flag (M2, Sigma), anti-HA (12CA5, Roche), anti-
ubiquitin and anti-b-actin (Biomol), anti-NFATc4 (Santa Cruz),
anti-His, anti-GSK3b, anti-mouse- and anti-rabbit-conjugatedation of European Biochemical Societies.
Y. Fan et al. / FEBS Letters 582 (2008) 4008–4014 4009antibodies (Cell signaling Technology). Cycloheximine and MG-132
were obtained from Biomol. LiCl, phenylephrine (PE) and cyclospor-
ine A (CsA) were purchased from Sigma.
2.2. Cell culture, transfection and Luciferase assay
293T cells and myocardial cells H9c2 were obtained from ATCC and
cultured in Dulbecco Modiﬁed Eagle Medium (DMEM) supplemented
with 10% fetal calf serum, penicillin (100 U/ml) and streptomycin
(100 lg/ml). Cells were transiently transfected using Lipofectamine
2000 (Invitrogen) or siRNA Transfection Reagent (SantaCruz) accord-
ing to manufacturers instruction. Luciferase assay was performed
using the Luciferase Assay System (Promega) as described [13]. Data
represent means ± S.E.M. of three independent assays.
2.3. Immunoprecipitation and immunoblotting
Lysates were extracted in cell lysis buﬀer containing 50 mm Tris (pH
7.4), 150 mm NaCl, 1% Nonidet P-40, and protease and phosphatase
inhibitor cocktail (Sigma). For immunoprecipitations, 1000 lg pro-
teins were incubated overnight at 4 C with anti-Flag antibody and
then precipitated the next day for 2 h with protein A/G (Upstate Bio-
technology). Immunoprecipitates were resolved by 6–8% SDS–PAGE
and analyzed by immunoblotting using appropriate antibodies [13].
The intensities of protein bands were measured using Gel-pro 4.5 Ana-
lyzer (Media Cybernetics, USA).2.4. Nickel–agarose chromatography and ubiquitination assay
Cells were transfected with indicated plasmids and lysed in Ni–aga-
rose lysis buﬀer (50 mM NaH2PO4, 300 mM NaCl, 5 mM imidazole,
0.05% Tween 20, 10 mM of N-ethylmaleimide, and complete protease
inhibitor). Ubiquitin-conjugated proteins were puriﬁed by nickel chro-
matography (Ni–NTA–agarose, Qiagen) and detected by immunoblot-
ting [14]. Ubiquitination assay in vivo was performed as described [13].2.5. Quantitative real-time RT-PCR analysis
Total RNA was puriﬁed from H9c2 cells with Trizol (Invitrogen).
Reverse-transcription was performed using ImProm-II reverse-trans-
criptase (Promega) with oligo-dT priming according to manufacturers
instruction. PCR was performed using Bio-RAD iQ5 Multicolor Real-
Time PCR Detection System with SYBR Green (Takara) as ﬂuores-
cent and ROX (Takara) as reference dyes. PCR primers for atria natri-
uretic factor (ANF), ß-myosin heavy chain (ß-MHC) and GAPDH
were used as described [13].Fig. 1. Modiﬁcation of NFATc4 was mediated by ubiquitination. (A) 293T
treated with MG-132 (10 lM) for 6 h before harvesting. His-Ub bound
immunoblotting with anti-Flag (upper) or anti-His (middle) antibodies. The e
antibodies (lower). (B) H9c2 cells were transfected with HA-Ub plasmids. Im
and analyzed by immunoblotting with anti-HA (upper) or anti-NFATc4 (mid
was examined with anti-HA or anti-NFATc4 (lower) antibodies.2.6. Statistical analysis
Data are presented as means ± S.E.M. Diﬀerences between groups
were analyzed for statistical signiﬁcance using ANOVA tests and Stu-
dents t-test. P < 0.05 was considered to indicate statistical signiﬁcance.3. Results
3.1. Modiﬁcation of NFATc4 by ubiquitination
The expression level and consequent transactivity of many
transcription factors are regulated by ubiquitin-mediated
proteolysis. To investigate whether NFATc4 is modiﬁed by
ubiquitination in vivo, nickel chromatography assay was per-
formed. As shown in Fig. 1A, ubiquitination of Flag-NFATc4
was readily detected in the presence of His-ubiquitin (His-Ub).
To further verify whether the endogenous NFATc4 is ubiqui-
tinated, H9c2 cells were transfected with HA-Ub and immuno-
precipitated with anti-NFATc4 antibodies followed by
immunoblotting with anti-HA or anti-NFATc4 antibodies.
As shown in Fig. 1B, marked ubiquitination of NFATc4 was
also detected in a dose-dependent manner (Fig. 1B). These
results suggest that NFATc4 is ubiquitinated in vivo.3.2. Proteasome-dependent degradation of NFATc4 reduces its
transcriptional activity
Ubiquitination modiﬁcation has been associated with protea-
some-dependent degradation of target proteins. To assess
whether ubiquitination promotes NFATc4 degradation by pro-
teasome, the stability of NFATc4 protein in 293T cells was
examined. The half-life of NFATc4 protein was markedly re-
duced in the presence of HA-Ub compared with vector control
(Fig. 2A). Moreover, overexpression of HA-Ub signiﬁcantly
decreased the level of endogenous NFATc4 proteins, whereas
treatment with MG-132 resulted in marked stabilization of
NFATc4 proteins compared with the cells without MG-132
(Fig. 2B). Furthermore, treatment with MG-132 dramatically
enhanced the level of ubiquitinated proteins of NFATc4cells were transfected with Flag-NFATc4 and His-Ub plasmids and
proteins were puriﬁed by nickel chromatography and analyzed by
xpression of NFATc4 in the cell extracts was examined with anti-Flag
munoprecipitation (IP) was performed with anti-NFATc4 antibodies
dle) antibodies. The expression of Ub and NFATc4 in the cell extracts
4010 Y. Fan et al. / FEBS Letters 582 (2008) 4008–4014(Fig. 2C). These ﬁndings indicate that ubiquitinated NFATc4 is
regulated through proteasome-mediated degradation.
To further examine the eﬀect of ubiquitination on NFATc4
transcriptional activity, Luciferase assay was performed with
IL-2-luc reporter [1,8]. As shown in Fig. 2D, NFATc4 mark-
edly enhanced the IL-2-luc reporter activity, whereas overex-
pression of HA-Ub repressed NFATc4-mediated activation
of the IL-2-luc reporter. As expected, treatment with MG-
132 increased the transcriptional activity of NFATc4. In
contrast, overexpression of antisense HA-Ub moderately
increased IL-2-luc activation (Fig. 2E). Together these results
suggest that ubiquitination inhibits the transcriptional activity
of NFATc4.
3.3. Degradation of NFATc4 is mediated by the K48-linked
polyubiquitin chains
To determine the mechanism of ubiquitination on NFATc4
stability, ubiquitination assay was performed in 293T cellsFig. 2. Ubiquitinated-NFATc4 was degradated by proteasome. (A) H9
cycloheximide (50 lg/ml) over time as indicated. The expression of NFATc4
or b-actin (middle) antibodies. The NFATc4 band intensities were measured (
treated with MG-132 (10 lM) for 6 h before harvesting. The expression of p
anti-b-actin (lower) antibodies. (C) 293T cells were transfected with Flag-NF
before harvesting. His-Ub bound proteins were analyzed as in Fig. 1A. (D)
NFATc4 and HA-Ub with or without MG-132 treatment. Luciferase activit
transfected with the reporter IL-2 alone or with NFATc4, HA-Ub or antisens
levels were analyzed by immunoblotting as indicated antibodies. *P < 0.01 vtransfected with wild-type ubiquitin or ubiquitin K48R mu-
tant, in which the lysine at position 48 of ubiquitin was re-
placed by arginine [15,16]. Transfection with wild-type
ubiquitin increased the NFATc4 ubiquitination and decreased
its protein level. In contrast, transfection with ubiquitin K48R
mutant markedly decreased the NFATc4 ubiquitination and
increased its protein level (Fig. 3A and B). Furthermore, over-
expression of wild-type ubiquitin markedly decreased NFATc4
transcriptional activity, while K48R-ubiquitin mutant had no
eﬀect (Fig. 3C). The results indicate that the degradation of
NFATc4 is mediated by the K48-linked polyubiquitin chains,
thereby leading to inhibition of its transcriptional activity.
3.4. GSK3b activation enhances NFATc4 ubiquitination and
inhibits its transcriptional activity
Previous ﬁndings revealed that NFATc4 is phosphorylated
by protein kinase GSK3b in cardiac myocytes and other cell
types [3,4]. This promoted us to investigate whether thec2 cells were transfected with HA-Ub plasmids and treated with
in the cell extracts was examined with anti-NFATc4 antibodies (upper)
lower panel). (B) H9c2 cells were transfected with HA-Ub plasmids and
roteins in the cell extracts was examined with anti-NFATc4 (upper) or
ATc4 and His-Ub plasmids and treated with MG-132 (10 lM) for 6 h
293T cells were cotransfected with the IL-2 Luciferase reporter, Flag-
y was measured 24 h after transfection. *P < 0.01. (E) 293T cells were
e HA-ubiquitin (AS HA-Ub). Luciferase activity was measured. Protein
s. NFATc4 alone.
Fig. 3. Degradation of NFATc4 is dependent on the K48-linked polyubiquitin chains. (A) 293T cells were transfected with the Flag-NFATc4 and
HA-Ub wt. or HA-Ub K48R mutant and treated with MG-132 (10 lM) for 6 h before harvesting. Immunoprecipitation was performed with anti-
Flag antibodies and analyzed by immunoblotting with anti-HA (upper) or anti-Flag (middle) antibodies. The expression of NFATc4 in the cell
extracts was examined with anti-Flag antibodies (lower). (B) H9c2 cells were transfected with the HA-Ub wt. or HA-Ub K48R mutant. The
expression of NFATc4 in the cell extracts was examined with anti-NFATc4. (C) 293T cells were transfected with Luciferase reporters (PPAR or
NFAT/AP-1), NFATc4, HA-Ub wt. or HA-Ub K48R mutant. Luciferase activity was assayed 24 h after transfection. *P < 0.01 vs. NFATc4 alone.
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tion and transactivation. As shown in Fig. 4A and B, overex-
pression of active GSK3b markedly increased NFATc4
ubiquitination and repressed its transcriptional activity. Con-
versely, dominant-negative GSK3b had an opposite eﬀect.
Furthermore, inhibition of endogenous GSK3b activation by
siRNA or LiCl treatment inhibited NFATc4 ubiquitination
and enhanced its transcriptional activity compared with con-
trol (Fig. 4C and D). These results suggest that GSK3b depen-
dent phosphorylation plays a signiﬁcant role for NFATc4
ubiquitination and transcriptional activity.
3.5. Calcineurin activation by PE aﬀects NFATc4 ubiquitination
and transcriptional activity
It is known that NFATs are dephosphorylated by calcineu-
rin in the cytoplasm and imported to the nucleus for their acti-
vation [1,2], we therefore tested the eﬀect of calcineurin on
NFATc4 ubiquitination and transcriptional activity. Cells
were treated with hypertrophic agent, PE or calcineurin inhib-
itor, cyclosporine A (CsA). As shown in Fig. 5A and B, treat-
ment with PE signiﬁcantly decreased NFATc4 ubiquitination
and increased its transcriptional activity, whereas CsA sub-
stantially had an opposite eﬀect. These results indicate that
activation of calcineurin inhibits the ubiquitination of
NFATc4 and enhances its transcriptional activity.
3.6. Both ubiquitin and GSK3b inhibit NFATc4-induced cardiac
gene expression
Because NFATc4 plays an important role in cardiac gene
expression and hypertrophy [6,10–12], we further asked
whether ubiquitin or GSK3b is able to aﬀect NFATc4-depen-
dent cardiac gene expression in H9c2 cells. Active NFATc4 orwild-type NFATc4 alone markedly induced the expression of
cardiac ANF and b-MHC (Fig. 6A and B). However, cotrans-
fection with ubiquitin or Ac-GSK3b signiﬁcantly inhibited
these gene expressions (Fig. 6A–D). Conversely, transfection
with Dn-GSK3b or LiCl treatment had an opposite eﬀect
(Fig. 6C and D). These ﬁndings indicate that the modiﬁcations
of ubiquitination and phosphorylation inhibit NFATc4-
dependent cardiac-speciﬁed gene expression.4. Discussion
In the present study, we demonstrated that NFATc4 is pre-
dominantly ubiquitinated and degradated through the protea-
some system. Ubiquitin-mediated modiﬁcation reduces
NFATc4-dependent transcriptional activity. Furthermore,
GSK3b dependent phosphorylation is required for eﬃcient
ubiquitination of NFATc4 and inhibition of its transactiva-
tion. Finally, both ubiquitination and phosphorylation in-
duced by GSK3b can regulate NFATc4-dependent cardiac
gene expression.
Previous studies have shown that NFATc4 plays important
role in the development of cardiovascular system [1,8]. How-
ever, the molecular mechanisms that regulate the stability
and activity of NFATc4 remain unclear. There is a growing
belief that posttranslational modiﬁcation by ubiquitin acts as
an important regulator of transcription factor activity [17].
Recent reports demonstrated that proteasome pathway is
involved in degradation of NFAT members such as NFATc2
and NFAT5 [18,19]. Consistent with this view, we found that
overexpression of ubiquitin promoted the ubiquitination and
degradation of NFATc4, and treatment with proteasome
4012 Y. Fan et al. / FEBS Letters 582 (2008) 4008–4014inhibitor MG-132 led to the accumulation of NFATc4 pro-
teins (Figs. 1 and 2), indicating that ubiquitination of NFATc4
is mediated through the proteasome-dependent degradation. It
is also known that that the ubiquitin lysine 48-linked poly-
ubiquitin chain functions as a signal for targeting substrates
to proteasome degradation, whereas ubiquitin lysine 63-linked
is involved in several non-degradative processes such as recep-
tor endocytosis and sorting, translation, as well as DNA dam-
age repair [14,20]. In this study, we demonstrated that
ubiquitination of NFATc4 was ubiquitin lysine-48-dependent
(Fig. 3A). Furthermore, we clearly observed that wild-type
ubiquitin resulted in decreased NFATc4 protein level and its
transactivation. However, the ubiquitin K48R mutant had
no eﬀect (Fig. 3B and C). Taken together, these data suggest
that NFATc4 is a target of the ubiquitin–proteasome system
in vivo.
Phosphorylation has been considered to play a critical role
in inﬂuencing protein ubiquitination, and in several cases the
target proteins were ﬁrst marked by phosphorylation for ubiq-Fig. 4. GSK3b regulates the NFATc4 ubiquitination and transcriptional acti
Dn-GSK3b and treated with MG-132 (10 lM) for 6 h before harvesting. Im
analyzed by immunoblotting with anti-His (upper) antibodies. The expres
immunoblotting as indicated (lower). (B) 293T cells were transfected with I
Luciferase activity was assayed. *P < 0.01 vs. NFATc4 alone. (C) H9c2 cells
treatment with LiCl (10 mM) for 6 h. Cells were treated with MG-132 (10 lM
(A). (D) 293T cells were cotransfected with IL-2 Luciferase reporter and siRN
for 6 h, and Luciferase activity was assayed. *P < 0.01 vs. control.uitin-mediated degradation [21,22]. In the case of NFATc4,
GSK3b as a ubiquitous serine/threonine protein kinase phos-
phorylates a series of sites in the N-terminal regulatory regions
of NFAT proteins and inactivates NFATs activity by prevent-
ing their accumulation in the nucleus [3,4]. We found that
cotransfection of active GSK3b signiﬁcantly enhanced
NFATc4 ubiquitination and repressed its transcriptional activ-
ity. In contrast, dominant-negative GSK3b, siRNA-GSK3b or
treatment with LiCl decreased NFATc4 ubiquitination and en-
hanced its transactivation (Fig. 4A–D), indicating that GSK3b
dependent phosphorylation is required for the eﬃcient ubiqui-
tination of NFATc4 and inhibition of its transcriptional activ-
ity. Recent evidences suggest that the calcineurin/NFATc4
pathway can be activated by classical hypertrophy inducers,
including PE, angiotensin II (ANG II), endothelin-1 (ET-1)
[13,23,24]. Activated calcineurin dephosphorylates NFATc4
for nuclear import [24]. In our case, we demonstrated that
treatment with PE, which is known to induce calcineurin activ-
ity, decreased NFATc4 ubiquitination and enhanced its tran-vity. (A) H9c2 cells were cotransfected with His-Ub and Ac-GSK3b or
munoprecipitation was performed with anti-NFATc4 antibodies and
sion of NFATc4 and GSK3b in the cell extracts was examined by
L-2 Luciferase reporter and Ac-GSK3b or Dn-GSK3b plasmids and
were cotransfected with His-Ub, siRNA-control or siRNA-GSK3b or
) for 6 h before harvesting. Immunoprecipitation was performed as in
A-GSK3b or siRNA-control for 36 h or treatment with LiCl (10 mM)
Fig. 6. Both ubiquitin and GSK3b repress NFATc4-induced cardiac-speciﬁc gene expression. (A, B) H9c2 cells were transfected with plasmids Ub,
active form of NFATc4 or wild-type NFATc4 as indicated. The mRNA level of ANF and b-MHC was determined by RT-PCR analysis. (C, D) H9c2
cells were transfected with plasmids Ub, NFATc4, Ac-GSK3b or Dn-GSK3b or treatment with LiCl as indicated. The mRNA level of ANF and
b-MHC was determined as in A and B. *P < 0.001 vs. NFATc4 alone.
Fig. 5. The eﬀect of calcineurin activation by PE on NFATc4 ubiquitination and transcriptional activity. (A) H9c2 cells were cotransfected with His-
Ub and treated with PE (100 lM) or CsA for 6 h. Immunoprecipitation was performed with anti-NFATc4 antibodies and analyzed by
immunoblotting with anti-His (upper) or anti-NFATc4 (middle) antibodies. The expression of NFATc4 in the cell extracts was examined by
immunoblotting (lower). (B) 293T cells were transfected with IL-2 Luciferase reporter and treated with PE (100 lM) or CsA for 6 h, and Luciferase
activity was assayed. *P < 0.01 vs. NFATc4 alone.
Y. Fan et al. / FEBS Letters 582 (2008) 4008–4014 4013
4014 Y. Fan et al. / FEBS Letters 582 (2008) 4008–4014scriptional activity, whereas CsA had opposite eﬀects (Fig. 4B
and C), indicating that activation of cacineurin by PE inhibits
NFATc4 ubiquitination and increases its transcriptional activ-
ity.
Cardiac hypertrophy is accompanied by the activation of a
set of fetal cardiac genes, including those encoding ANF and
b-MHC [24]. Activation of several transcription factors,
including NFATc1-c4, contributes in part to the changes in
cardiac gene expression [7,10,25,26]. Among these factors,
NFATc4 is the major form of NFAT family member, and its
nuclear localization is suﬃcient to induce cardiac hypertrophy
[10–12]. Importantly, cardiac-speciﬁc expression of activated
GSK3b diminished stimuli-induced hypertrophy, at least in
part, by preventing nuclear localization of NFAT [25]. In the
present study, we found that both ubiquitination and GSK3b
dependent phosphorylation of NFATc4 repressed the expres-
sion of cardiac ANF and b-MHC. However, dominant-nega-
tive GSK3b or LiCl markedly increased the expression of
these genes (Fig. 6A–D). These data demonstrate that modiﬁ-
cations of ubiquitination and phosphorylation induced by
GSK3b play an important role in regulating NFATc4-depen-
dent cardiac gene activity.
In conclusion, our results demonstrate that the ubiquitin–
proteasome system plays a crucial role in the stability of
NFATc4 protein and its transcriptional activity. We proposed
a model depicting the antagonistic eﬀects of GSK3b and calci-
neurin on NFATc4 ubiquitination and transcriptional activity.
GSK3b activation antagonizes calcineurin signaling by phos-
phorylation of NFATc4 proteins and cytoplasmic transloca-
tion, thereby leading to ubiquitination and proteasomal
degradation. Further studies to identify the E3 ligases for
NFATc4 will open a new view into the mechanism for modu-
lating cardiac development and hypertrophy.
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